CDTX RA Capital Healthcare Fund LP buys $100.0M worth of shares
Jul 01, 2025, 4:35 AM
0.00%
What does CDTX do
Cidara Therapeutics, a San Diego-based biotechnology company with 69 employees, focuses on developing targeted immunotherapies for serious diseases, including oncology and antiviral treatments. Its lead candidate, CBO421, targets solid tumors, while CD388 addresses influenza prevention and treatment.
RA Capital Healthcare Fund LP bought 2,272,727 shares of CDTX on 26 June at $44.00 per share, worth a total of $100.0M. They now own 3,365,523 CDTX shares, or a 208% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.